Dr Rachel Archer BSc, PhD (Sheffield) (formerly Jackson)
Research Fellow
Address:
HEDS, ScHARR
University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA
Tel: (+44) (0)114 222 0793
Fax: (+44) (0)114 272 4095
Email: r.jackson@sheffield.ac.uk
Room: 1019
Biography
I read for my first degree in genetics and microbiology before undertaking a PhD and postdoctoral research in molecular microbiology. I joined the Section of Public Health at ScHARR in August 2004 before moving to HEDS in August 2007.
Research interests
My research interests include:
- systematic reviews of evidence for clinical effectiveness
- systematic reviews of public health interventions
- development of methods for systematic reviewing and evidence synthesis
Teaching Interests
I am currently involved as a lecturer in the teaching of systematic review methods on undergraduate and postgraduate taught causes. I lead the delivery of a successful external short courses in systematic review methods entitled "The ScHARR Systematic Reviews Course: Practical Skills for Undertaking Reviews". I also play a strategic role in the delivery of teaching as a member of the HEDS Teaching Functional Working Group.
Professional Activities
I am a member of the ScHARR Technology Assessment Group (ScHARR-TAG) and the ScHARR Public Health Collaborating Centre. I have undertaken leading and contributory roles in high quality research for the National Institute for Health and Clinical Excellence, the NHS and other funding organisations.
Current Projects
I am current involved in the NICE Single Technology Appraisal process and a Health Technology Assessment of the use of routine echocardiography in the management of stroke and transient ischaemic attack.
Recent projects have included:
- Assessment of evidence to inform Public Health Programme Guidance relating to the prevention and early indication of alcohol use disorders in adults and adolescents (funded by the National Institute for Health and Clinical Excellence) (lead systematic reviewer).
- Health Technology Assessment of the use of oseltamivir, amantadine and zanamivir for the prophylasix of influenza (commissioned by the National Coordinating Centre for Health Technology Assessment (NCCHTA) on behalf of the National Institute for Health and Clinical Excellence(lead systematic reviewer).
Key publications
Recent publications include the following:
- Tappenden P, Jackson R, Cooper K, Simpson E, Rees A. Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza. Health Technology Assessment 2009 Feb;13(11):iii, ix-xii, 1-246
- Campbell F, Cooper K, Czoski-Murray C, Jackson R, Jones R, Karnon J, Lloyd-Jones M, Wilkinson A(authors in alphabetical order). Technical patient safety solutions for prevention of ventilator-associated pneumonia in adults: Selective Decontamination of the Digestive Tract. Assessment Report for the Review Body for Interventional Procedures (ReBIP); National Institute for Health and Clinical Excellence (NICE) 2008
- Baird WO, Jackson RJ, Ford H, Bull P, Busby M, Evangelou N, Zajicek J. Holding personal information in a disease-specific register: The perspectives of people with multiple sclerosis and professionals on consent and access. Journal of Medical Ethics 2009 Feb; 35(2):92-6
- Jackson RG, Baird WO, Davis-Reynolds L, Smith C, Blackburn S, Allesbrook J. Qualitative analysis of parents' information needs and psychosocial experiences. Health Information and Libraries Journal 2008; 25(1):31-7